Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Reviewing your finances regularly is essential for success. Explore various ways to conduct reviews and enhance your financial strategy.
18,365 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Is intuitive surgical right now? The robotics leader faces macro headwinds and strong long term demand. This guide br...
A focused bet on telecom infrastructure amid sector volatility shows how savvy funds seek durable cash flow. Explore ...
The surge in digital payments and online lending has unlocked fresh opportunities in fintech. This guide shows you ho...
When the tech market cools, patient investors can find real opportunities. This guide highlights two blue‑chip names ...
Investors face a clear choice between two CRM juggernauts. This guide breaks down HubSpot and Salesforce, weighing gr...
CD rates have paused as investors await the Federal Reserve’s next move. This report explains when to lock in a CD ra...
Hasbro stock jumped today after a stronger quarter and higher guidance. This guide explains the earnings drivers, wha...
A wave of positive economic data has the Fed blinking toward rate cuts, yet stock investors fret about what comes nex...
Is Occidental Petroleum a smart move for your portfolio in 2026? This guide breaks down the debt story, cash flow, an...
Team (TISI) kicks off 2025 with a solid Q1 showing that blends growing customer demand with margin challenges. This a...
If you’ve got $5,000 to invest, these three AI-driven stock picks offer a balanced blend of growth potential and prac...